Loading clinical trials...
Loading clinical trials...
China Survey of Proton Pump Inhibitor Empirical Treatment in Management of Outpatients With Gastroesophageal Reflux Disease
Conditions
Locations
10
China
Research Site
Beijing, China
Research Site
Benijin, China
Research Site
Changchun, China
Research Site
Chongqing, China
Research Site
Guangzhou, China
Research Site
Hangzhou, China
Start Date
December 4, 2015
Primary Completion Date
December 28, 2016
Completion Date
December 28, 2016
Last Updated
November 17, 2017
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions